Concepedia

David L. MacLeod

DL

Statistics

Publications

14

Citations

1.4K

H-Index

14

Active since

1988

Affiliations

University of Guelph(Current)

Gilead Sciences (United States)

Seattle Children's Hospital

University of Washington

Gilead Sciences (Canada)

David L. MacLeod is an author at University of Guelph specializing in life sciences, microbiology, and medical microbiology.

Publications per year

1988–2012

14

Publications

14

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.

Peter B. Challoner, Kimberley Smith, J D Parker et al. · Proceedings of the National Academy of Sciences · 1995 · 617 citations

, , +17

Activities of Tobramycin and Six Other Antibiotics against <i>Pseudomonas aeruginosa</i> Isolates from Patients with Cystic Fibrosis

Ribhi M. Shawar, David L. MacLeod, Richard L. Garber et al. · Antimicrobial Agents and Chemotherapy · 1999 · 128 citations · Full text

, , +9

Reproduction of Edema Disease of Swine with Purified Shiga-like Toxin-II Variant

David L. MacLeod, Carlton Gyles, Brian Wilcock · Veterinary Pathology · 1991 · 124 citations

, , +14

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

David L. MacLeod, L. M. Barker, Judith L. Sutherland et al. · Journal of Antimicrobial Chemotherapy · 2009 · 100 citations · Full text

, , +16

Aminoglycoside‐Resistance Mechanisms for Cystic Fibrosis<i>Pseudomonas aeruginosa</i>Isolates Are Unchanged by Long‐Term, Intermittent, Inhaled Tobramycin Treatment

David L. MacLeod, Laura E. Nelson, Ribhi M. Shawar et al. · The Journal of Infectious Diseases · 2000 · 97 citations

, , +17

1–5 of 14